Our unique approach implements technologies that are targeted, controllable and multi-genic.
Advanced Gene Therapy Solutions
Triple-Gene’s multi-genic therapies are designed to drive expression of three or more potent gene products targeted at reprogramming cells and organs toward a positive health state. Our genetic architecture is built upon a suite of integrated platform technologies licensed from Intrexon Corporation. We employ non-viral delivery of DNA to develop therapeutics that address the underlying causes of cardiovascular disease.